These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 19148137)

  • 1. In situ analysis of the antigen-processing machinery in acute myeloid leukaemic blasts by tissue microarray.
    Hoves S; Aigner M; Pfeiffer C; Laumer M; Obermann EC; Mackensen A
    Leukemia; 2009 May; 23(5):877-85. PubMed ID: 19148137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of human lymphocyte antigen class I antigen-processing machinery defects in renal cell carcinoma lesions with special emphasis on transporter-associated with antigen-processing down-regulation.
    Seliger B; Atkins D; Bock M; Ritz U; Ferrone S; Huber C; Störkel S
    Clin Cancer Res; 2003 May; 9(5):1721-7. PubMed ID: 12738726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coordinated downregulation of the antigen presentation machinery and HLA class I/beta2-microglobulin complex is responsible for HLA-ABC loss in bladder cancer.
    Romero JM; Jiménez P; Cabrera T; Cózar JM; Pedrinaci S; Tallada M; Garrido F; Ruiz-Cabello F
    Int J Cancer; 2005 Feb; 113(4):605-10. PubMed ID: 15455355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome.
    Meissner M; Reichert TE; Kunkel M; Gooding W; Whiteside TL; Ferrone S; Seliger B
    Clin Cancer Res; 2005 Apr; 11(7):2552-60. PubMed ID: 15814633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human leukocyte antigen and antigen processing machinery component defects in astrocytic tumors.
    Facoetti A; Nano R; Zelini P; Morbini P; Benericetti E; Ceroni M; Campoli M; Ferrone S
    Clin Cancer Res; 2005 Dec; 11(23):8304-11. PubMed ID: 16322289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of the MHC class I antigen-processing machinery after oncogenic transformation of murine fibroblasts.
    Seliger B; Harders C; Lohmann S; Momburg F; Urlinger S; Tampé R; Huber C
    Eur J Immunol; 1998 Jan; 28(1):122-33. PubMed ID: 9485192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total loss of MHC class I in colorectal tumors can be explained by two molecular pathways: beta2-microglobulin inactivation in MSI-positive tumors and LMP7/TAP2 downregulation in MSI-negative tumors.
    Cabrera CM; Jiménez P; Cabrera T; Esparza C; Ruiz-Cabello F; Garrido F
    Tissue Antigens; 2003 Mar; 61(3):211-9. PubMed ID: 12694570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MHC class I-deficient metastatic tumor variants immunoselected by T lymphocytes originate from the coordinated downregulation of APM components.
    Garcia-Lora A; Martinez M; Algarra I; Gaforio JJ; Garrido F
    Int J Cancer; 2003 Sep; 106(4):521-527. PubMed ID: 12845647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional deficiencies of components of the MHC class I antigen pathway in human tumors of epithelial origin.
    Delp K; Momburg F; Hilmes C; Huber C; Seliger B
    Bone Marrow Transplant; 2000 May; 25 Suppl 2():S88-95. PubMed ID: 10933198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired expression of proteasome subunits and human leukocyte antigens class I in human colon cancer cells.
    Miyagi T; Tatsumi T; Takehara T; Kanto T; Kuzushita N; Sugimoto Y; Jinushi M; Kasahara A; Sasaki Y; Hori M; Hayashi N
    J Gastroenterol Hepatol; 2003 Jan; 18(1):32-40. PubMed ID: 12519221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of HLA class I antigen processing molecules: an immune escape mechanism of renal cell carcinoma?
    Atkins D; Ferrone S; Schmahl GE; Störkel S; Seliger B
    J Urol; 2004 Feb; 171(2 Pt 1):885-9. PubMed ID: 14713847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MHC class I antigen processing pathway defects, ras mutations and disease stage in colorectal carcinoma.
    Atkins D; Breuckmann A; Schmahl GE; Binner P; Ferrone S; Krummenauer F; Störkel S; Seliger B
    Int J Cancer; 2004 Mar; 109(2):265-73. PubMed ID: 14750179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced membrane major histocompatibility complex class I density and stability in a subset of human renal cell carcinomas with low TAP and LMP expression.
    Seliger B; Höhne A; Knuth A; Bernhard H; Ehring B; Tampé R; Huber C
    Clin Cancer Res; 1996 Aug; 2(8):1427-33. PubMed ID: 9816317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WHO grade associated downregulation of MHC class I antigen-processing machinery components in human astrocytomas: does it reflect a potential immune escape mechanism?
    Mehling M; Simon P; Mittelbronn M; Meyermann R; Ferrone S; Weller M; Wiendl H
    Acta Neuropathol; 2007 Aug; 114(2):111-9. PubMed ID: 17541610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
    Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of the transporter for antigen presentation, proteasome subunits, and class I major histocompatibility complex in tumor cell lines.
    Johnsen A; France J; Sy MS; Harding CV
    Cancer Res; 1998 Aug; 58(16):3660-7. PubMed ID: 9721876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the MHC class I antigen presentation machinery in human embryonal carcinomas: evidence for deficiencies in TAP, LMP and MHC class I expression and their upregulation by IFN-gamma.
    Seliger B; Dunn T; Schwenzer A; Casper J; Huber C; Schmoll HJ
    Scand J Immunol; 1997 Dec; 46(6):625-32. PubMed ID: 9420627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of defective HLA-I expression with antigen processing machinery and their association with clinicopathological characteristics in Kazak patients with esophageal cancer.
    Ayshamgul H; Ma H; Ilyar S; Zhang LW; Abulizi A
    Chin Med J (Engl); 2011 Feb; 124(3):341-6. PubMed ID: 21362330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Markedly decreased expression of TAP1 and LMP2 genes in HLA class I-deficient human tumor cell lines.
    Singal DP; Ye M; Ni J; Snider DP
    Immunol Lett; 1996 May; 50(3):149-54. PubMed ID: 8803612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of proteasomes, transporter for antigen presentation (TAP), and beta 2-microglobulin in the processing of bacterial or particulate antigens via an alternate class I MHC processing pathway.
    Song R; Harding CV
    J Immunol; 1996 Jun; 156(11):4182-90. PubMed ID: 8666786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.